EP 1239871 A1 20020918 - USE OF GLP-1 AGONISTS FOR THE INHIBITION OF BETA CELL DEGENERATION
Title (en)
USE OF GLP-1 AGONISTS FOR THE INHIBITION OF BETA CELL DEGENERATION
Title (de)
VERWENDUNG VON GLP-1-AGONISTEN ZUR HEMMUNG DER DEGENERATION VON BETA-ZELLEN
Title (fr)
UTILISATION D'AGONISTES GLP-1 POUR L'INHIBITION DE LA DEGENERATION DES CELLULES BETA
Publication
Application
Priority
- DK 0000625 W 20001110
- DK PA199901628 A 19991112
- DK PA200000270 A 20000222
Abstract (en)
[origin: WO0135988A1] This invention relates to a method for modulating, inhibiting or decreasing or preventing beta cell degeneration, loss of beta cell function, beta cell dysfunction, and/or death of beta cells, such as necrosis or apoptosis of beta cells in a subject comprising administering a GLP-1 agonist to said subject.
IPC 1-7
IPC 8 full level
A61K 38/00 (2006.01); A61K 38/26 (2006.01); A61K 45/00 (2006.01); A61P 3/10 (2006.01); A61P 5/50 (2006.01); A61P 9/08 (2006.01); A61P 25/00 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01); A61P 35/00 (2006.01); A61P 37/02 (2006.01); A61P 43/00 (2006.01); C07K 14/605 (2006.01)
CPC (source: EP)
A61K 38/26 (2013.01); A61P 3/10 (2017.12); A61P 5/50 (2017.12); A61P 9/08 (2017.12); A61P 25/00 (2017.12); A61P 25/16 (2017.12); A61P 25/28 (2017.12); A61P 35/00 (2017.12); A61P 37/02 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 0135988A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0135988 A1 20010525; AU 1269501 A 20010530; EP 1239871 A1 20020918; JP 2003516322 A 20030513
DOCDB simple family (application)
DK 0000625 W 20001110; AU 1269501 A 20001110; EP 00974350 A 20001110; JP 2001537978 A 20001110